BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2008
View Archived Issues
ABT-335 and statin combinations effective in phase III dyslipidemia studies
Read More
Heart failure model reveals novel activity of inotropic agent CK-452
Read More
Follow-up data support effect of green tea catechins in preventing prostate cancer
Read More
Oral AS-606521 inhibits uterine activity in pregnant rhesus monkeys
Read More
Takeda joins an initiative to discover biomarkers
Read More
PharmaMar's Yondelis granted orphan drug status in Switzerland, EMEA approval for phase III trial
Read More
Recent Merck & Co. patent discloses new remedial options for glaucoma
Read More
Myostatin-inhibiting gene therapy shows benefit in a mouse model of Duchenne muscular dystrophy
Read More
Chronogen patent divulges new treatment alternatives for age-related disorders
Read More
Recent Dainippon Sumitomo patent describes novel therapeutic agents for dermatitis
Read More
Carfilzomib receives FDA orphan drug designation in multiple myeloma
Read More
Eisai to resume E-2012 clinical trial in Alzheimer's disease
Read More
New antiatherosclerotic agent reported in recent Merck & Co. patent
Read More
BioMarker Pharmaceuticals launches Gene Essence genome analysis test in the U.S.
Read More
Monogram enters agreement to provide resistance and tropism testing of Progenics' PRO-140
Read More
ISTA reports results from clinical trial of once-daily Xibrom for ocular inflammation
Read More
EMEA accepts for review Cell Therapeutics' MAA for Xyotax in NSCLC
Read More
U.S. phase III clinical trial of Kamada's intravenous AAT meets primary endpoint
Read More
Cosmo begins phase I trials of anti-androgen cream as skin disorder therapy
Read More
Meda files for European approval of BioDelivery Sciences' BEMA fentanyl
Read More
Teijin enters license agreement in Japan with Dong Wha for DW-1350 in osteoporosis
Read More
ProtAffin is awarded EUR 1.1 million research grant in Austria for development of PA-401
Read More
EnVivo initiates clinical safety and biomarker study of EVP-6124 in schizophrenia
Read More
The FDA accepts FibroGen's complete response for clinical holds of FG-2216 and FG-4592
Read More